Andrew Lynn Asher bought $1.0M of Centene (CNC)
Executed Nov 13 2024, disclosed Nov 13 2024, the same day.
Over the 21 trading sessions from the disclosed entry session (Nov 13 2024), the stock returned -1.3% (delay-adjusted); from the execution session (Nov 13 2024), -1.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
Andrew Lynn Asher (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Centene Corporation (CNC). Across 1 priced purchase filing, the average 21-session return was -1.3% from execution and -1.3% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of CNC (17,200 sh × $58.14, as filed), executed Nov 13 2024.
Healthcare · Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→